Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
simultaneous radiotherapy
RADIATION
2 trials
Sponsors
Wu Jieping Medical Foundation
, CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Conditions
Locally Advanced Unresectable Esophageal Squamous Carcinoma
Non Small Cell Lung Cancer, Oligometastatic
Phase 1
A Study of Docetaxel for Injection (Albumin-bound) and SG001 in Combination With Cisplatin and Simultaneous Radiotherapy for Locally Advanced Unresectable Esophageal Squamous Carcinoma.
Not yet recruiting
NCT06136988
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Locally Advanced Unresectable Esophageal Squamous Carcinoma
Start: 2023-12-31
End: 2028-04-30
Target: 129
Updated: 2023-11-18
Phase 2
The Value of Radiotherapy in the Oligometastatic Non-squamous Non-small Cell Lung Cancer With Clinical Benefits From Erlotinib as Second-line Treatment
NCT01796288
Wu Jieping Medical Foundation
Non Small Cell Lung Cancer, Oligometastatic
Start: 2012-10-31
End: 2017-10-31
Target: 200
Updated: 2013-02-21
Related Papers
Multimodality local consolidative treatment versus conventional care of advanced lung cancer after first-line systemic anti-cancer treatment: study protocol for the RAMON multicentre randomised controlled trial with an internal pilot
BMJ Open
2023-12-01
1 citations
Study protocol for the SARON trial: a multicentre, randomised controlled phase III trial comparing the addition of stereotactic ablative radiotherapy and radical radiotherapy with standard chemotherapy alone for oligometastatic non-small cell lung cancer.
2018-04-17
57 citations